|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
1 months to Mar 31, 2022
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| CASH FLOWS USED IN OPERATING ACTIVITIES: | |||||
| Cash flows used in operations | |||||
| Dividend received | |||||
| Dividend received | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Net cash flow used in operating activities | |||||
| CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES: | |||||
| Purchase of property and equipment | |||||
| Payments for acquisitions of associates and financial assets at fair value through profit or loss (note 4 and note 5) | |||||
| Consolidation of subsidiaries upon gain of control (Appendix E and note 4F, Appendix D and note 4E, Appendix B and note 4D) | |||||
| Loans to associates (note 4F, note 4I, note 4M, note 4N) | |||||
| Proceeds from sale of financial assets at fair value through profit of loss and securities of an associate (note 5, note 4G) | |||||
| Changes in short term deposits | |||||
| Investments and acquisitions of associates (note 4) | |||||
| Acquisitions of investments at fair value through profit or loss (note 5) | |||||
| Deconsolidation of Jeffs’ Brands (Appendix B and note 4E) | |||||
| Consolidation of subsidiaries upon gain of control (Appendix C and note 4F) | |||||
| Purchase of intangible assets (note 10 and supplemental disclosure of cash flow information) | |||||
| Loans to associates (note 17b2) | |||||
| Loans to others (note 7b) | |||||
| Proceeds from sale of financial assets at fair value through profit or loss and securities of an associate (note 4C and note 5) | |||||
| Repayment of loans to associates (note 4L) | |||||
| Changes in short term deposits and restricted cash | |||||
| Net cash flow used in investing activities | |||||
| Proceeds from issuance of shares and warrants by subsidiaries, net of issuance costs (note 4E, note 4F) | |||||
| Receipt of short-term loans (note 4E, note 4F) | |||||
| Repayment of short-term loans (note 4E, note 4F) | |||||
| CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of shares and warrants by subsidiaries, net of issuance costs (note 4E, note 4F) | |||||
| Purchase of shares from non-controlling interests (note 4F) | |||||
| Cash paid to non-controlling interests by Viewbix Inc. (note 4F) | |||||
| Proceeds from deemed issuance of shares by Charging Robotics Ltd. (note 4K) | |||||
| Receipt of short-term loans (note 4E, note 4F) | |||||
| Receipt of short-term convertible loans (note 4F) | |||||
| Repayment of short-term loans (note 4E, note 4F) | |||||
| Receipt of long-term loans (note 4E) | |||||
| Repayment of long-term loans (note 4F) | |||||
| Repayment of related party debt (note 4D) | |||||
| Dividend paid to shareholders (note 14) | |||||
| Proceeds from issuance of common stock in a private placement offering by Charging Robotics Inc. (note 4K) | |||||
| Issuance of shares and warrants in connection with a private placement issued by Viewbix Inc. (note 4F) | |||||
| Dividend paid to shareholders | |||||
| Dividend paid to non-controlling interests (note 4F) | |||||
| Principal elements of lease liability | |||||
| Proceeds from issuance of prefunded shares, net of issuances costs (note 13) | |||||
| Net cash flow from (used in) financing activities | |||||
| DECREASE IN CASH AND CASH EQUIVALENTS | |||||
| BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR | |||||
| GAINS (LOSSES) FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS | |||||
| BALANCE OF CASH AND CASH EQUIVALENTS AT END OF YEAR | |||||
| Income (Loss) for the year before taxes on income | |||||
| Loss for the year before taxes on income | |||||
| Depreciation and amortization | |||||
| Loss (Gain) from changes in fair value of financial assets at fair value through profit or loss | |||||
| Changes in fair value of warrants | |||||
| Changes in fair value of warrants issued to third party investors by a consolidated subsidiary | |||||
| Share of net loss of associates accounted for using the equity method | |||||
| Finance expenses (income) | |||||
| Viewbix June 2024 Facility Agreement (note 4F and note 5) | |||||
| Changes in fair value of warrants (note 5) | |||||
| Equity losses | |||||
| Net loss (Gain) from derecognition of investments accounted for using the equity method | |||||
| Finance expenses, net | |||||
| Amortization of excess purchase price of associates | |||||
| Dividend received | |||||
| Loss (Gain) from sales of securities of an investment (note 5) | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Share based compensation to employees and service providers | |||||
| Gain from initial recognition of assets and liabilities upon consolidation of Gix Internet (note 4F) | |||||
| Loss from deconsolidation of Jeffs’ Brands (note 4E) | |||||
| Loss (Gain) from sales of investments (note 5) | |||||
| Impairment of goodwill and other intangible assets | |||||
| Decrease (Increase) in trade accounts receivable | |||||
| Decrease (Increase) in inventory | |||||
| Goodwill | |||||
| Decrease (Increase) in deferred offering costs | |||||
| Decrease (Increase) in other current assets | |||||
| Increase (decrease) in accrued compensation expenses | |||||
| Decrease in deferred offering costs | |||||
| Increase (Decrease) in trade accounts payable | |||||
| CASH FLOWS USED IN OPERATIONS | |||||
| Substantial modification of shareholders loans recorded in equity (note 4E) | |||||
| Issuance of ordinary shares upon conversion of shareholders loans (note 4E) | |||||
| Non-cash investment in Laminera (note 4N) | |||||
| Non-cash investment in ClearMind (note 4O) | |||||
| CASH FLOWS USED IN OPERATIONS | |||||
| Decrease in accrued compensation expenses | |||||
| Increase (Decrease) in accrued expenses and other current liabilities | |||||
| Right of use assets obtained in exchange for lease liabilities | |||||
| Non-cash investment in Metagramm Software Ltd. (note 4O) | |||||
| Non-cash investment in Polyrizon Ltd. (note 4H) | |||||
| Non-cash investment in SciSparc Ltd. (note 4E) | |||||
| Consideration payable to the sellers of Fort Products Ltd. (note 4E) | |||||
| Consideration payable to the seller of SciSparc Nutraceuticals Inc. (note 4E) | |||||
| Non-cash investments in securities | |||||
| Non-cash sale and purchase of securities (note 4J) | |||||
| Consideration payable by Jeffs’ Brands to sellers of intangible assets (note 4E) | |||||
| Conversions of loans into shares (note 4H, note 4L and note 4P) | |||||
| Purchase of a software license on credit (note 4D) | |||||
| Dividend included in other payables | |||||
| Decrease in long-term related party payable in exchange for advertising services (note 4D) | |||||
| Substantial modification of shareholders loans recorded in equity | |||||
| Issuance of ordinary shares upon conversion of shareholders loans | |||||
| Non-cash investment in Laminera Flow Optimization Ltd. (note 4M) | |||||
| Non-cash investment in Clearmind Medicine Inc. | |||||
| Deemed extinguishment and re-issuance of debt by Viewbix Inc. (note 4F) | |||||
| Derecognition of right of use asset and lease liability upon lease termination (see note 4F) | |||||
| Deferred debt issuance costs paid in shares (note 4F) | |||||
| Deferred debt issuance costs paid in warrants (note 4F) | |||||
Loading...